The presence of C3 is consistent with the well-reported increases in C3 in the plasma, which are associated with high probability in development of AMD (Tsai et al., 2022); unfortunately, given the challenges in collecting AH fluid compared to blood, this particular change is unlikely to prove useful for diagnostic purposes. This evidence concerns the gene C3 and age-related macular degeneration.